*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • I am a 74-year-old woman in good health. I was diagnosed with pyoderma gangrenosum on my left leg. I was in a ...
Vilobelimab is a first-in-class anti-human complement factor C5a monoclonal antibody. The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ...
Studies of the epidemiology of acute glomerulonephritis (AGN) following pyoderma reported over the past 15 years have been reviewed. Investigations in Alabama, at Red Lake in Minnesota, and in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Ulcerative pyoderma gangrenosum is a rare disease with ...
RITTER'S disease, exfoliative dermatitis of the newborn, was first described by Ritter von Ritter-shain in 1878. Many investigators, since the work of Winternitz, 1 in 1898, suggested Staphylococcus ...
Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has completed a post-marketing observational study titled ‘Post ...
For months, an experimental medication has kept him alive, but the clinical trial that provided it is losing its funding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback